Filing Flows › Health Care › Cosmos Health (COSM)
Cosmos Health (COSM) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 18, 2026 · Cosmos Health (COSM) Q2 2026 earnings results →
Q2 2026 Revenue up 29% year over year to $19.0M · 32¢ of every $1 of revenue lost · operating margin -15.4%
Cosmos Health made $19.0M in Q2 2026 (+29% Y/Y). Operating margin -15.4%, net loss $6.1M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 18, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $19.0M in Q2 2026, up 29% year over year and up 6% from the previous quarter.
Gross margin was 8.0%, up 0.1 points from Q2 2025. Operating costs exceeded revenue by $2.9M, an operating margin of -15.4%. Operating expenses grew 16% against revenue growth of 29%. The fastest-growing cost line was Sales & marketing (+353%). The quarter ended with a net loss of $6.1M, wider than the previous quarter's $2.8M loss. Net interest and other expense of $3.2M was the main reason.
Operating cash flow was −$1.7M. Non-cash charges added back $348K of depreciation and amortization and $559K of share-based compensation. Working capital and other items added $3.5M. Capital expenditures of $64K exceeded it, leaving free cash flow of −$1.8M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 18, 2026 | $19.0M | +29% | -15.4% | −$6.1M | −$1.7M |
| Q1 2026 | 10-Q | May 20, 2026 | $17.9M | +31% | -12.2% | −$2.8M | −$1.1M |
| Q4 2025 | 10-K | Apr 15, 2026 | $19.7M | +38% | -57.9% | −$10.1M | −$4.6M |
| Q3 2025 | 10-Q | Nov 14, 2025 | $17.1M | +38% | -10.6% | −$5.4M | −$2.5M |
| Q2 2025 | 10-Q | Aug 18, 2025 | $14.7M | +12% | -17.9% | −$2.8M | −$1.2M |
| Q1 2025 | 10-Q | May 15, 2025 | $13.7M | -6% | -6.1% | −$818K | −$186K |
| Q4 2024 | 10-K | Apr 15, 2025 | $14.2M | -10% | -63.0% | −$9.5M | −$3.8M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Cosmos Health
Cosmos Health Inc. was incorporated in 2009 in Nevada and is a diversified, vertically integrated global healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of innovative medicines and repurposing drugs as well as operator of a telehealth platform. As a global company we are harnessing our expertise and stepping up innovation to continue the momentum behind the discovery, delivery, and expanded development of modern pharmaceutical and nutraceutical products.
In its own words, from its 10-K, filed Apr 15, 2026.
Cosmos Health against its Wholesale-Drugs, Proprietaries & Druggists' Sundries peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +29% against the peers' median +5%. Operating margin: -15.4% against the peers' median 1.3%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| COSM Cosmos Health | Q2 2026 | $19.0M | +29% | -15.4% |
| MCK McKesson | Q2 FY27 | $111.0B | +8% | 1.4% |
| COR Cencora | Q3 FY26 | $84.8B | +5% | 1.3% |
| CAH Cardinal Health | Q1 FY27 | $67.5B | +6% | 1.1% |
| HLF Herbalife | Q3 2026 | $1.4B | +6% | 10.3% |
| NUS Nu Skin Enterprises | Q3 2026 | $311M | -15% | 1.6% |
| MEDS DataMeds AI | Q2 2026 | $1.8M | -77% | -412.7% |
| STEK Stemtech | Q2 2026 | $629K | -10% | -20.0% |
| ESYN HWH International | Q2 2026 | $64K | -79% | 328.1% |
Source: Cosmos Health 10-Q on SEC EDGAR · CIK 1474167 · Wholesale-Drugs, Proprietaries & Druggists' Sundries
13F: who owns COSM and who is buying
More on COSM
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results